|
1
|
Libby P, Ridker PM and Hansson GK:
Progress and challenges in translating the biology of
atherosclerosis. Nature. 473:317–325. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Beaufrère H, Vet DM, Cray C, Ammersbach M
and Tully TN Jr: Association of plasma lipid levels with
atherosclerosis prevalence in psittaciformes. J Avian Med Surg.
28:225–231. 2014. View
Article : Google Scholar
|
|
3
|
Herrington W, Lacey B, Sherliker P,
Armitage J and Lewington S: Epidemiology of atherosclerosis and the
potential to reduce the global burden of atherothrombotic disease.
Circ Res. 118:535–546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dou Y, Chen Y, Zhang X, Xu X, Chen Y, Guo
J, Zhang D, Wang R, Li X and Zhang J: Non-proinflammatory and
responsive nanoplatforms for targeted treatment of atherosclerosis.
Biomaterials. 143:93–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao Y, Ding Y, Chen H, Chen H and Zhou J:
Targeting Krüppel-like factor 5 (KLF5) for cancer therapy. Curr Top
Med Chem. 15:699–713. 2015. View Article : Google Scholar
|
|
6
|
Bell SM, Zhang L, Xu Y, Besnard V, Wert
SE, Shroyer N and Whitsett JA: Kruppel-like factor 5 controls
villus formation and initiation of cytodifferentiation in the
embryonic intestinal epithelium. Dev Biol. 375:128–139. 2013.
View Article : Google Scholar :
|
|
7
|
Ha JM, Yun SJ, Jin SY, Lee HS, Kim SJ,
Shin HK and Bae SS: Regulation of vascular smooth muscle phenotype
by cross-regulation of krüppel-like factors. Korean J Physiol
Pharmacol. 21:37–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao Y, Wu K, Chen Y, Zhou J, Du C, Shi Q,
Xu S, Jia J, Tang X, Li F, et al: Beyond proliferation: KLF5
promotes angiogenesis of bladder cancer through directly regulating
VEGFA transcription. Oncotarget. 6:43791–43805. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Owens GK: Regulation of differentiation of
vascular smooth muscle cells. Physiol Rev. 75:487–517. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang W, Zhang Y, Wang L, Li J, Li Y, Yang
X and Wu Y: MircroRNA-152 prevents the malignant progression of
atherosclerosis via down-regulation of KLF5. Biomed Pharmacother.
109:2409–2414. 2019. View Article : Google Scholar
|
|
11
|
Zhang YN, Xie BD, Sun L, Chen W, Jiang SL,
Liu W, Bian F, Tian H and Li RK: Phenotypic switching of vascular
smooth muscle cells in the 'normal region' of aorta from
atherosclerosis patients is regulated by miR-145. J Cell Mol Med.
20:1049–1061. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Song X, Li Z and Liu B: Long
non-coding RNAs in coronary atherosclerosis. Life Sci. 211:189–197.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bian W, Jing X, Yang Z, Shi Z, Chen R, Xu
A, Wang N, Jiang J, Yang C, Zhang D, et al: Downregulation of
LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell
injury and atherosclerosis. Aging (Albany NY). 12:6385–6400. 2020.
View Article : Google Scholar
|
|
14
|
Wang YQ, Xu ZM, Wang XL, Zheng JK, Du Q,
Yang JX and Zhang HC: LncRNA FOXC2-AS1 regulated proliferation and
apoptosis of vascular smooth muscle cell through targeting
miR-1253/FOXF1 axis in atherosclerosis. Eur Rev Med Pharmacol Sci.
24:3302–3314. 2020.PubMed/NCBI
|
|
15
|
Huang T, Zhao HY, Zhang XB, Gao XL, Peng
WP, Zhou Y, Zhao WH and Yang HF: LncRNA ANRIL regulates cell
proliferation and migration via sponging miR-339-5p and regulating
FRS2 expression in atherosclerosis. Eur Rev Med Pharmacol Sci.
24:1956–1969. 2020.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Libby P, Buring JE, Badimon L, Hansson GK,
Deanfield J, Bittencourt MS, Tokgözoğlu L and Lewis EF:
Atherosclerosis. Nat Rev Dis Primers. 5:562019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Geovanini GR and Libby P: Atherosclerosis
and inflammation: Overview and updates. Clin Sci (Lond).
132:1243–1252. 2018. View Article : Google Scholar
|
|
19
|
Wang HH, Garruti G, Liu M, Portincasa P
and Wang DQ: Cholesterol and lipoprotein metabolism and
atherosclerosis: Recent advances in reverse cholesterol transport.
Ann Hepatol. 16(Suppl 1: s3-105): S27–S42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taleb S: Inflammation in atherosclerosis.
Arch Cardiovasc Dis. 109:708–715. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stary HC: Natural history and histological
classification of atherosclerotic lesions: An update. Arterioscler
Thromb Vasc Biol. 20:1177–1178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Virmani R, Kolodgie FD, Burke AP, Farb A
and Schwartz SM: Lessons from sudden coronary death: A
comprehensive morphological classification scheme for
atherosclerotic lesions. Arterioscler Thromb Vasc Biol.
20:1262–1275. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Simionescu N, Vasile E, Lupu F, Popescu G
and Simionescu M: Prelesional events in atherogenesis. Accumulation
of extracellular cholesterol-rich liposomes in the arterial intima
and cardiac valves of the hyperlipidemic rabbit. Am J Pathol.
123:109–125. 1986.PubMed/NCBI
|
|
24
|
Libby P: Mechanisms of acute coronary
syndromes. N Engl J Med. 369:883–884. 2013.PubMed/NCBI
|
|
25
|
Quillard T, Araújo HA, Franck G, Shvartz
E, Sukhova G and Libby P: TLR2 and neutrophils potentiate
endothelial stress, apoptosis and detachment: Implications for
superficial erosion. Eur Heart J. 36:1394–1404. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wen Y, Chun Y, Lian ZQ, Yong ZW, Lan YM,
Huan L, Xi CY, Juan LS, Qing ZW, Jia C and Ji ZH:
circRNA-0006896-miR1264-DNMT1 axis plays an important role in
carotid plaque destabilization by regulating the behavior of
endothelial cells in atherosclerosis. Mol Med Rep. 23:3112021.
View Article : Google Scholar :
|
|
27
|
Qian X, Wang H, Wang Y, Chen J, Guo X and
Deng H: Enhanced autophagy in GAB1-Deficient vascular endothelial
cells is responsible for atherosclerosis progression. Front
Physiol. 11:5593962021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu H, Ma S, Sun L, Gao J and Zhao C:
TGF-β1 upregulates the expression of lncRNA-ATB to promote
atherosclerosis. Mol Med Rep. 19:4222–4228. 2019.PubMed/NCBI
|
|
29
|
Deng L, Bradshaw AC and Baker AH: Role of
noncoding RNA in vascular remodelling. Curr Opin Lipidol.
27:439–448. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Z: Progress and prospects of long
noncoding RNAs in lipid homeostasis. Mol Metab. 5:164–170. 2015.
View Article : Google Scholar
|
|
31
|
Hu YW, Zhao JY, Li SF, Huang JL, Qiu YR,
Ma X, Wu SG, Chen ZP, Hu YR, Yang JY, et al:
RP5-833A20.1/miR-382-5p/ NFIA-dependent signal transduction pathway
contributes to the regulation of cholesterol homeostasis and
inflammatory reaction. Arterioscler Thromb Vasc Biol. 35:87–101.
2015. View Article : Google Scholar
|
|
32
|
Xu TP, Ma P, Wang WY, Shuai Y, Wang YF, Yu
T, Xia R and Shu YQ: KLF5 and MYC modulated LINC00346 contributes
to gastric cancer progression through acting as a competing
endogeous RNA and indicates poor outcome. Cell Death Differ.
26:2179–2193. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Peng WX, He RZ, Zhang Z, Yang L and Mo YY:
LINC00346 promotes pancreatic cancer progression through the
CTCF-mediated Myc transcription. Oncogene. 38:6770–6780. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang N and Chen X: A positive feedback
loop involving the LINC00346/β-catenin/MYC axis promotes
hepatocellular carcinoma development. Cell Oncol (Dordr).
43:137–153. 2020. View Article : Google Scholar
|
|
35
|
Tong WH, Mu JF and Zhang SP: LINC00346
accelerates the malignant progression of colorectal cancer via
competitively binding to miRNA-101-5p/MMP9. Eur Rev Med Pharmacol
Sci. 24:6639–6646. 2020.PubMed/NCBI
|
|
36
|
Pordzik J, Pisarz K, De Rosa S, Jones AD,
Eyileten C, Indolfi C, Malek L and Postula M: The potential role of
platelet-related microRNAs in the development of cardiovascular
events in high-risk populations, including diabetic patients: A
review. Front Endocrinol (Lausanne). 9:742018. View Article : Google Scholar
|
|
37
|
Li Z, Wang S, Zhao W, Sun Z, Yan H and Zhu
J: Oxidized low-density lipoprotein upregulates microRNA-146a via
JNK and NF-κB signaling. Mol Med Rep. 13:1709–1716. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng HS, Sivachandran N, Lau A, Boudreau
E, Zhao JL, Baltimore D, Delgado-Olguin P, Cybulsky MI and Fish JE:
MicroRNA-146 represses endothelial activation by inhibiting
pro-inflammatory pathways. EMBO Mol Med. 5:1017–1034. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Del Monte A, Ar royo AB, Andrés-Manzano
MJ, García-Barberá N, Caleprico MS, Vicente V, Roldan V,
Gonzalez-Conejero R, Martínez C and Andrés V: MiR-146a deficiency
in hematopoietic cells is not involved in the development of
atherosclerosis. PLoS One. 13:e01989322018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: The role of miR-126 in embryonic angiogenesis, adult vascular
homeostasis, and vascular repair and its alterations in
atherosclerotic disease. J Mol Cell Cardiol. 97:47–55. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tang F and Yang TL: MicroRNA-126
alleviates endothelial cells injury in atherosclerosis by restoring
autophagic flux via inhibiting of PI3K/Akt/mTOR pathway. Biochem
Biophys Res Commun. 495:1482–1489. 2018. View Article : Google Scholar
|
|
42
|
Shang L, Quan A, Sun H, Xu Y, Sun G and
Cao P: MicroRNA-148a-3p promotes survival and migration of
endothelial cells isolated from Apoe deficient mice through
restricting circular RNA 0003575. Gene. 711:1439482019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kattoor AJ, Kanuri SH and Mehta JL: Role
of Ox-LDL and LOX-1 in atherogenesis. Curr Med Chem. 26:1693–1700.
2019. View Article : Google Scholar
|
